Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMA.
Journal: American journal of hematology
Published: April 02, 2026
Real-world analysis of CPX-351 in AML-MR: A multicentre study from the MARROW consortium.
Journal: British journal of haematology
Published: September 11, 2025
Menin inhibitors for the treatment of acute myeloid leukemia: challenges and opportunities ahead.
Journal: Journal of hematology & oncology
Published: June 30, 2024
Emerging small molecular inhibitors as targeted therapies for high-risk acute myeloid leukemias.
Journal: Expert review of hematology
Published: July 05, 2023
Novel investigational approaches for high-risk genetic subsets of AML: TP53, KMT2A, FLT3.
Journal: Hematology. American Society of Hematology. Education Program
Published: December 09, 2022
Survival, response rates, and post-transplant outcomes in patients with Acute Myeloid Leukemia aged 60-75 treated with high intensity chemotherapy vs. lower intensity targeted therapy.
Journal: Frontiers in oncology
Published: August 11, 2022
Venetoclax and acute myeloid leukaemia: an expanding new frontier.
Journal: The Lancet. Haematology
Published: April 08, 2022
Evaluating Blinatumomab for the Treatment of Relapsed/Refractory ALL: Design, Development, and Place in Therapy.
Journal: Blood and lymphatic cancer : targets and therapy
Published: August 01, 2020
AML with Myelodysplasia-Related Changes: Development, Challenges, and Treatment Advances.
Journal: Genes
Published: June 15, 2020
Recent advances in non-surgical management of cancer in the elderly.
Journal: F1000Research
Published: November 12, 2018
Last Updated: 09/26/2026